Related Experiment Video
Updated: Sep 6, 2025
Plasmid-derived DNA Strand Displacement Gates for Implementing Chemical Reaction Networks
Published on: November 25, 2015
A Molecular Logic Gate for Developing "AND" Logic Probes and the Application in Hepatopathy Differentiation
Mengqi Chen1, Chunhong Wang1, Zexuan Ding1
1Beijing National Laboratory for Molecular Sciences, Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.
This study introduces a novel molecular logic gate for enhanced disease diagnosis. The AND gate enables dual-stimuli control for precise biomarker detection, improving accuracy in identifying conditions like liver disease.
Area of Science:
- Biochemistry
- Molecular Biology
- Medical Diagnostics
Background:
- Current disease diagnosis and therapy are hindered by the lack of single, specific biomarkers.
- Multi-analyte detection is crucial for improving diagnostic and therapeutic targeting accuracy.
- AND-gated logic systems offer a potential solution for enhanced specificity.
Purpose of the Study:
- To develop a novel molecular logic gate system for dual-controlled release of functional molecules.
- To engineer AND logic probes with improved signal-to-background contrast for disease detection.
- To create a specific AND logic probe for diagnosing hepatopathy by detecting monoamine oxidase (MAO) and leucine aminopeptidase (LAP).
Main Methods:
- Design and synthesis of a novel "AND" molecular logic gate based on differential intramolecular cyclization rates.
- Development of several AND logic probes responsive to various stimuli.
- Construction of a specific AND logic probe for MAO and LAP detection.
- In vitro testing in living cells and in vivo validation in mouse models.
- Application of the probe for differentiating cirrhotic from hepatitis B in patient blood samples.
Main Results:
- The developed AND logic gate enables faster cargo release in the presence of both stimuli.
- AND logic probes demonstrate significantly improved signal-to-background contrast compared to monoresponsive probes.
- The MAO/LAP-responsive AND probe functions effectively in living cells and mouse models.
- The probe successfully differentiates between cirrhotic and hepatitis B patients using blood samples.
Conclusions:
- The novel AND molecular logic gate provides a robust platform for developing highly specific diagnostic tools.
- AND logic probes offer enhanced sensitivity and specificity for disease detection.
- This technology holds promise for accurate hepatopathy diagnosis and potentially other complex diseases.
